+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 40Years - 90Years
All Genders
ID07353424

Randomized Trial of Polyphenol-Rich Salicornia Extract to Slow Cognitive Decline in Patients Aged 40 to 90 with Lacunar Stroke

Led by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Updated on 2026-01-20

300

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of a polyphenol-rich dietary supplement based on Salicornia extract and B vitamins B-salicornia on small vessel neurovascular disease in patients with lacunar infarcts. This multicenter randomized controlled trial aims to assess whether this supplement can help slow cognitive decline and improve outcomes, using cognitive assessments and blood markers as key measures. The study includes 300 patients diagnosed with lacunar infarcts within the last year and confirmed by MRI. Participants are randomly assigned to receive either 500 mg daily of the B-salicornia supplement for six months or continue with standard clinical care without the supplement. The study follows a PROBE design, meaning that treatment is open-label but outcomes are evaluated in a blinded manner. Blood tests and cognitive and gait assessments are conducted before and after the six-month treatment period. During the study, participants will undergo routine blood tests to monitor vascular parameters including homocysteine and cholesterol levels. Cognitive function will be measured using the Montreal Cognitive Assessment MOCA and physical capacity by the six-minute walk test 6MWT. Adherence is tracked by counting returned supplement capsules, and safety is monitored by recording adverse events. The total participation time for each person is approximately six months.

CONDITIONS

Brief Title

A Multicenter Randomized Clinical Trial Compared With Standard Clinical Practice to Evaluate the Efficacy of a Polyphenol-rich Salicornia Extract in the Progression of Cognitive Decline in a Cohort of Patients With Lacunar Infarcts (SALACUNAR)

Research Team

C

CRISTINA LÓPEZ AZCÁRATE

C

CARMEN DOMÍNGUEZ RUIZ

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here